Generated: December 11, 2017
DrugPatentWatch Database Preview
Procainamide hydrochloride - Generic Drug Details
« Back to Dashboard
What are the generic drug sources for procainamide hydrochloride and what is the scope of procainamide hydrochloride freedom to operate?
is the generic ingredient in seven branded drugs marketed by Ascot, Idt Australia Ltd, Ivax Sub Teva Pharms, Lannett, Lederle, Roxane, Vangard, Watson Labs, Parke Davis, Panray, Apothecon, Abraxis Pharm, Hospira, Intl Medication, Nexus Pharms, Pharmafair, Smith And Nephew, Solopak, Warner Chilcott, West-ward Pharms Int, Ani Pharms Inc, Inwood Labs, Sandoz, Parkedale, and King Pharms, and is included in seventy NDAs. Additional information is available in the individual branded drug profile pages.
There are eight drug master file entries for procainamide hydrochloride. Five suppliers are listed for this compound.
Summary for procainamide hydrochloride
Pharmacology for procainamide hydrochloride
Medical Subject Heading (MeSH) Categories for procainamide hydrochloride
|Watson Labs||PROCAINAMIDE HYDROCHLORIDE||procainamide hydrochloride||CAPSULE;ORAL||083795-001||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Abraxis Pharm||PROCAINAMIDE HYDROCHLORIDE||procainamide hydrochloride||INJECTABLE;INJECTION||089416-001||Nov 17, 1986||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Watson Labs||PROCAINAMIDE HYDROCHLORIDE||procainamide hydrochloride||TABLET, EXTENDED RELEASE;ORAL||088534-001||Dec 3, 1984||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Panray||PROCAPAN||procainamide hydrochloride||CAPSULE;ORAL||083553-002||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Apothecon||PRONESTYL||procainamide hydrochloride||TABLET;ORAL||017371-002||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Warner Chilcott||PROCAINAMIDE HYDROCHLORIDE||procainamide hydrochloride||INJECTABLE;INJECTION||089529-001||May 3, 1988||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Parkedale||PROCAN SR||procainamide hydrochloride||TABLET, EXTENDED RELEASE;ORAL||088489-001||Jan 16, 1985||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Vangard||PROCAINAMIDE HYDROCHLORIDE||procainamide hydrochloride||CAPSULE;ORAL||087643-001||Jun 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|King Pharms||PROCANBID||procainamide hydrochloride||TABLET, EXTENDED RELEASE;ORAL||020545-001||Jan 31, 1996||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Watson Labs||PROCAINAMIDE HYDROCHLORIDE||procainamide hydrochloride||CAPSULE;ORAL||087021-001||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Expired Orange Book Patents for Generic Ingredient: procainamide hydrochloride
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.